Literature DB >> 28449862

Innate lymphoid cells in atherosclerosis.

Daniel Engelbertsen1, Andrew H Lichtman2.   

Abstract

The family of innate lymphoid cells (ILCs) consisting of NK cells, lymphoid tissue inducer cells and the 'helper'-like ILC subsets ILC1, ILC2 and ILC3 have been shown to have important roles in protection against microbes, regulation of inflammatory diseases and involved in allergic reactions. ILC1s produce IFN-γ upon stimulation with IL-12 and IL-18, ILC2s produce IL-5 and IL-13 responding to IL-33 and IL-25 while ILC3s produce IL-17 and IL-22 after stimulation with IL-23 or IL-1. Although few studies have directly investigated the role for ILCs in atherosclerosis, several studies have investigated transcription factors and cytokines shared by ILCs and T helper cells. In this review we summarize our current understanding of the role of ILC in atherosclerosis and discuss future directions.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Atherosclerosis; Cytokines; Inflammation; Innate lymphoid cells; Mouse models

Mesh:

Year:  2017        PMID: 28449862     DOI: 10.1016/j.ejphar.2017.04.030

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Authors:  Philip M Carlucci; Monica M Purmalek; Amit K Dey; Yenealem Temesgen-Oyelakin; Simantini Sakhardande; Aditya A Joshi; Joseph B Lerman; Alice Fike; Michael Davis; Jonathan H Chung; Martin P Playford; Mohammad Naqi; Pragnesh Mistry; Gustavo Gutierrez-Cruz; Stefania Dell'Orso; Faiza Naz; Taufiq Salahuddin; Balaji Natarajan; Zerai Manna; Wanxia L Tsai; Sarthak Gupta; Peter Grayson; Heather Teague; Marcus Y Chen; Hong-Wei Sun; Sarfaraz Hasni; Nehal N Mehta; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-04-19

2.  Interleukin-17A is associated with flow-mediated dilation and interleukin-4 with carotid plaque in persons with HIV.

Authors:  Celestine N Wanjalla; Tecla M Temu; Mona Mashayekhi; Christian M Warren; Bryan E Shepherd; Rama Gangula; Hubaida Fuseini; Samuel Bailin; Curtis L Gabriel; Pandu Gangula; Meena S Madhur; Spyros Kalams; Simon A Mallal; David G Harrison; Joshua A Beckman; John R Koethe
Journal:  AIDS       Date:  2022-02-14       Impact factor: 4.632

3.  The role of polycarbonate monomer bisphenol-A in insulin resistance.

Authors:  Milos Pjanic
Journal:  PeerJ       Date:  2017-09-13       Impact factor: 2.984

4.  Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes.

Authors:  Jing Li; Jing Wu; Mingyou Zhang; Yang Zheng
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

5.  Circulating levels of IL-33 are elevated by obesity and positively correlated with metabolic disorders in Chinese adults.

Authors:  Haoneng Tang; Ning Liu; Xiaojing Feng; Yanyi Yang; Yiyuan Fang; Siqi Zhuang; Yufeng Dai; Meilian Liu; Lingli Tang
Journal:  J Transl Med       Date:  2021-02-04       Impact factor: 5.531

Review 6.  Inflammatory Cells in Atherosclerosis.

Authors:  Marcelle Mehu; Chandrakala Aluganti Narasimhulu; Dinender K Singla
Journal:  Antioxidants (Basel)       Date:  2022-01-26

Review 7.  Immune system and atherosclerosis: Hostile or friendly relationship.

Authors:  Iman Razeghian-Jahromi; Ali Karimi Akhormeh; Mahboobeh Razmkhah; Mohammad Javad Zibaeenezhad
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

Review 8.  Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases.

Authors:  Masashi Ikutani; Susumu Nakae
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 9.  Crosstalk between epithelium, myeloid and innate lymphoid cells during gut homeostasis and disease.

Authors:  Sonia Ghilas; Ryan O'Keefe; Lisa Anna Mielke; Dinesh Raghu; Michael Buchert; Matthias Ernst
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.